HeartBeam ECG Registry for heart monitoring
Part of Heart & circulation clinical trials.
This registry collects ECG data from people who are already getting an ECG for their heart health. It uses a device called HeartBeam to see if it works as well as the standard ECG machine.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You need to have an ECG (electrocardiogram, a test that checks your heart’s electrical activity) as part of your regular care.
- You must be willing and able to sign a consent form to participate in the registry.
- You cannot have had recent (within 30 days) open surgery or open wounds on your chest or belly.
- You must be able to complete an ECG with both the standard machine and the HeartBeam device.
- Your medical condition should be stable enough that joining the registry won’t interfere with your treatments.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is testing a new wearable device that tracks your heart's electrical activity. It is designed to see if it works as well as a standard ECG machine.
This study uses a special ECG to better tell apart different types of fast heart rhythms in people scheduled for a procedure called ablation. The goal is to improve diagnosis and treatment for conditions like atrial fibrillation and other supraventricular tachycardias.
This is a hospital-based study that collects standardized information about adults with specific heart conditions—heart failure, coronary artery disease, or atrial fibrillation. It may help doctors and researchers better understand these diseases and improve future care.
This registry collects information from people who have had or are scheduled to have a heart rhythm test or a procedure to restore a normal heartbeat at University Hospital Düsseldorf. It helps doctors understand more about heart rhythm problems and treatments over time.
This registry collects information on people with atrial fibrillation to understand how different treatments affect their health and quality of life over time.
This study registers people who are referred to cardiology or genetics for heart-failure–type symptoms or heart/cardiogenetic screening. It helps doctors understand how monitoring platforms may support diagnosis and follow-up.
Hear when a new Atrial fibrillation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.